PMA device
FreeStyle Libre Pro Flash Glucose Monitoring System
Abbott Diabetes Care, Inc. · Sensor, Glucose, Invasive (MDS, Class III) · First FDA decision Sep 23, 2016, newest May 12, 2020Diabetes
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
6
PMA pathway
Device trials
38
Naming "FreeStyle Libre Pro"
MAUDE reports
49
Brand "FreeStyle Libre Pro", since 2015
PubMed studies
111
Mentioning "FreeStyle Libre Pro"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing FreeStyle Libre Pro Flash Glucose Monitoring System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 6 decisions filed under this name.
- FreeStyle Libre Pro Flash Glucose Monitoring SystemPMA supplement
P150021-S046 · Decided May 12, 2020 · 207 days after receipt · Normal 180 Day Track
Device type: Sensor, glucose, invasive (MDS) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "FreeStyle Libre Pro", any status and sponsor, newest update first.
- Glucose Pattern in Infertile Women Receiving Assisted Reproduction Using Continuous Glucose MonitoringActive, not recruiting
Shanghai 6th People's HospitalAcademic, hospital or other
NCT06863337 · 100 participants (planned) · Start Mar 26, 2025 · Primary completion Jun 30, 2026
Device: CGM · For: Infertility Female
Sites: Shanghai, China
37 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "FreeStyle Libre Pro", and for the whole product code for context.
This brand
49 reports: 15 malfunction, 34 injury, 0 death
Whole product code MDS
232,139 reports: 226,671 malfunction, 5,201 injury, 215 death
Newest reports for this brand
- FreeStyle Libre ProMalfunction
2954323-2026-425066 · Received Sep 21, 2026 · Event dated Jan 10, 2024
Device type: Sensor, Glucose, Invasive (MDS)
Device problem as coded: Incorrect, Inadequate or Imprecise Result or Readings
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "FreeStyle Libre Pro"[tiab]. The summary above synthesizes these.
- Continuous glucose monitoring with FreeStyle Libre PRO sensor in patients with type 2 diabetes and end-stage renal failure on haemoDIALysis (FSLPRO-DIAL pilot study).
Henry Z, Villar E, Chauvet C, et al. · Acta Diabetol · 2024
- Skin reactions to Freestyle Libre Pro among individuals with and without diabetes.
Rama Chandran S, Choo KJL, Tan HC, et al. · Diabet Med · 2025Letter
- Comparison of Accuracy of Freestyle Libre Pro and Medtronic iPro2 Continuous Glucose Monitoring Systems in Pregnancy.
Golla KK, Gupta Y, Goyal A, et al. · Diabetes Technol Ther · 2023Observational Study
- The Performance of Freestyle Libre Pro Flash Continuous Glucose Monitoring in Hospitalized Patients Treated with an Intravenous Insulin Infusion for Acute Prednisolone-Induced Hyperglycemia.
Chen AX, Radhakutty A, Zimmermann A, et al. · Diabetes Technol Ther · 2024
- Comparison of the FreeStyle Libre Pro Flash Continuous Glucose Monitoring (CGM) System and Point-of-Care Capillary Glucose Testing in Hospitalized Patients With Type 2 Diabetes Treated With Basal-Bolus Insulin Regimen.
Galindo RJ, Migdal AL, Davis GM, et al. · Diabetes Care · 2020Research Support, Non-U.S. Gov't, Comment
- Glucose variability in 6-12-month-old healthy infants.
Hauschild M, Monnard C, Eldridge AL, et al. · Front Nutr · 2023
- Breaking through diabetes management barriers: Assessing the accuracy of Freestyle Libre Pro flash continuous glucose monitoring in diabetes patients with myocardial infarction.
Shen L, Xu L, Zhang C, et al. · Digit Health · 2024
- Comparison of glucose monitoring between Freestyle Libre Pro and iPro2 in patients with diabetes mellitus.
Kumagai R, Muramatsu A, Fujii M, et al. · J Diabetes Investig · 2019Comparative Study
- Continuous glucose monitoring using the FreeStyle Libre Pro iQ in presymptomatic type 1 diabetes.
Weiss A, Huber E, Reinmüller F, et al. · Diabetologia · 2026
- Responses of Driver-Athletes to Repeated Driving Stints.
Potkanowicz ES, Ferguson DP, Greenshields JT · Med Sci Sports Exerc · 2021
- Ambulatory glucose profile in diabetes-related dementia.
Ogawa Y, Shimizu S, Takenoshita N, et al. · Geriatr Gerontol Int · 2019
- Accuracy of the professional flash glucose monitoring system FreeStyle Libre Pro in hospitalized individuals with type 2 diabetes mellitus receiving standardized basal-bolus insulin therapy.
Aberer F, Haberl HC, Elsayed H, et al. · Diabetes Obes Metab · 2024Letter
Other devices of this type
Also filed under product code MDS.
- Dexcom G4 Platinum Continuous Glucose Monitoring System and Dexcom 5 Mobile Continuous Glucose Monitoring SystemDexcom, Inc. · PMA 2018
- G5 Mobile Continuous Glucose Monitoring SystemDexcom, Inc. · PMA 2024
- Freestyle Navigator Continuous Glucose Monitoring SystemAbbott Laboratories · PMA 2011
- Paradigm Real-Time Insulin PumpMedtronic Minimed · PMA 2015
- Medtronic Minimed Continuous Glucose Monitoring SystemMedtronic Minimed · PMA 2011
- Guardian Connect SystemMedtronic Minimed · PMA 2025
- Dexcom Seven SystemDexcom, Inc. · PMA 2009
- Guardian RtMedtronic Minimed · PMA 2006
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.